This inventor holds 9 USPTO granted patents and 17 published patent applications and 1 EPO patent. Top assignee: Aquestive Therapeutics, Inc.. Active years: 2021-2025.
Location History:
- Annandale, NJ (US) (2021 - 2022)
- Pittstown, NJ (US) (2023 - 2024)
Company Filing History:
Years Active: 2021-2025
Title: The Innovations of Stephen Paul Wargacki
Introduction
Stephen Paul Wargacki is a notable inventor based in Annandale, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 9 patents. His work focuses on enhancing drug delivery methods, which can have a profound impact on patient care.
Latest Patents
Wargacki's latest patents include innovative methods and compositions aimed at improving treatment efficacy. One of his notable inventions is related to oral and nasal compositions and methods of treatment, specifically a method of administering diazepam that accounts for food effects. Another significant patent involves enhanced delivery of epinephrine and prodrug compositions, which describe pharmaceutical compositions with improved active component permeation properties.
Career Highlights
Wargacki is currently associated with Aquestive Therapeutics, Inc., a company dedicated to advancing therapeutic solutions. His work at Aquestive Therapeutics has allowed him to explore and develop groundbreaking pharmaceutical technologies that address critical healthcare needs.
Collaborations
Throughout his career, Wargacki has collaborated with talented individuals such as Alexander Mark Schobel and Stephanie Marie Varjan. These collaborations have contributed to the innovative environment that fosters the development of new pharmaceutical solutions.
Conclusion
Stephen Paul Wargacki's contributions to the field of pharmaceuticals through his patents and work at Aquestive Therapeutics, Inc. highlight his commitment to improving drug delivery methods. His innovative spirit continues to drive advancements in patient care and treatment efficacy.